GlaxoSmithKline Consumer Healthcare Australia Pty Ltd—Children’s Panadol 5-12 Suspension (Strawberry and Orange) 200mL

Identifying features

Children’s Panadol 5-12 Suspension Strawberry
48mg/mL suspension, pack size 200mL
Batch Numbers: 136418 and 136444
Expiry Dates: FEB 18 and FEB 18
AUST R 178302

Children’s Panadol 5-12 Suspension Orange
48mg/mL suspension, pack size 200mL
Batch Number: 136443
Expiry Date: FEB 18
AUST R 178303

This recall is limited to these three batches only.
No other variant, batches or pack sizes of Children’s Panadol are affected by this recall.

What are the defects?

There is a possibility of a small quantity of particulate contamination in an ingredient that is used to manufacture the products listed above.

What are the hazards?

An ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.

What should consumers do?

If consumers have a bottle of any of the three batches listed above, they should not use it. They are instructed to return it to the place of purchase for a refund or call GlaxoSmithKline's customer service line for further information and support.
GlaxoSmithKline Consumer Healthcare: 1800 028 533.

Traders who sold this product

All pharmacies across Australia.

Where the product was sold
Dates available for sale
  • 4 April 2016 - 19 May 2016

Recall advertisements and supporting documentation

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category